Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nissim Silanikove, Fira Shapiro, Adi Rauch & Gabriel Leitner

Similar presentations


Presentation on theme: "Nissim Silanikove, Fira Shapiro, Adi Rauch & Gabriel Leitner"— Presentation transcript:

1 Nissim Silanikove, Fira Shapiro, Adi Rauch & Gabriel Leitner
Distribution of Xanthine Dehydrogenase and Xanthine Oxidase in milk fractions : Evidence for post-transcriptional regulation of Xanthine Oxidase in the frame of the mammary innate immune defense system Nissim Silanikove, Fira Shapiro, Adi Rauch & Gabriel Leitner

2 Nitrite NADH NitrateNAD Or 2H2O2 SOD

3 N=O Reaction of Lactoperoxidase with Hydrogen peroxide and Nitrite
Nitric Oxide is a Free Radical 1. LPO + H2O LPO compound 1 2. LPO compound I + NO LPO compound II + ●NO2 3. LPO compound II + NO LPO + ●NO2 N=O

4 Scenario of NO cycling and metabolism in mammary secretion (Free radicals Biol Med, 2005)

5 Question Number 1 In the mammary gland, XOR has an essential, non-enzymatic, structural role in fat secretion (Vorbach et al. Genes Dev 2002, 16:3223) It is well established that XOR associated with fat secretion is located within the inner side of MFGM ) e.g. J. Physiol 2002, 545:567) Do we have sufficient XO to support its role in innate immunity? (Free radicals biol Med 2005, 38: 1139 )

6 Xanthine + hypoxanthine and uric acid concentration in oxytocin-induced and mature milk

7 Question Number 2 As mature fresh milk do not contains measurable amount of xanthine, but contains uric acid in the range of micro-molar, it is important to know whether it derived from milk xanthine or secreted as uric acid? Fresh milk (i.e., milk secreted into the alveoli within 5 to 10 min before sampling) was obtained at the end of noon-milking following injection of oxytocine.

8 Distribution of xanthine oxidase, alkaline phosphatase and acid phosphatase in milk fractions
Xanthine oxidase Alkaline phosphatase Acid phosphatase % of total % of total % of total Whoe milk Fat* (MFGM) WMP Phos.lipids Casein Truly soluble

9 Distribution of enzymes inside and outside of WMP membranes
XO (U/ml) XD (U/ ml) XD/XO Total XD/XO Inside AlP (U/ml) AcP (U/ml) Intact Total

10 Distribution of enzymes in MFGM with and without plasmin deactivation
With plasmin deactivation Without plasmin deactivation XO (U/g) ± ± 0.6 XD (U/g) ± XD/XO Total ± XD/XO inside ± AlP (U/g) ± ± 15 AcP (U/g) ± ± 9

11 Distribution of protein in milk fractions
Total protein Casein Protein in WMP Protein in MFGM g/l % of total g/l % of total g/Kg % of total g/Kg % of total

12 Lipid composition (as % of dry matter) in whey membrane particles (WMP) and milk fat globule membranes (MFGM) WMP MFGM Average SD Average SD Total lipid Lipid P Phos.lipids

13 Question Number 3 Does XO-derived oxidative stress play a role in sub-clinical mastitis; i.e., under conditions that do not elicit an apparent classical inflammatory symptoms

14 The model: Each cow tested had at least
one uninfected quarter (NBF) and one of the other quarters infected with one of the following bacteria: Number Bacteria 33 NBF 23 Streptococci 11 CNS 3 E. Coli 9 S. aureus + - Cork 2005

15 Uric Acid (micro-molar)
Uric acid and nitrate in sub-clinically infected glands Nitrate (micro-molar) Uric Acid (micro-molar) Bacteria 19 ± 9a 35 ± 13a NBF 38 ± 12b 72 ± 14b Strep. DG 17 ± 11a 38 ± 14a CNS 42 ± 12b 85 ±15b E. coli 20 ± 11a 39 ± 19a S. aureus BOLFA 2006

16 Clotting time and curd firmness
(V) Clotting time (sec) Bacteria 6.58±0.2 650±63 NBF 1.02±0.3 2490±340 Strep. 3.80±0.8 1255±468 CNS 0.92±0.3 2590±370 E. coli 3.28±0.7 1078±193 S. aureus Cork 2005

17

18

19 Question Number 4 Does XO-derived oxidative stress play a role in clinical mastitis; i.e., under conditions that elicit an apparent classical inflammatory symptoms

20 The model: Each cow tested
was infused in one quarter once with Casein hydrolyzate, lipopolysaccharide, or saline, and samples from each gland were sampled for two days post-treatment BOLFA 2006

21 Effect of infusion of CNH and LPS into the mammary gland on the immune cell population
Treatment SCC (×1000) PMN (%) CD4+ (% CD8+ (%) CD14+ (%) Control ±20a ±3.3a ±0.9a ±1.6a ±1.8a CNH ±324b ±7b ±1.1a ±2.0b ±2.2b LPS ±793c ±9.1c ±2.2b ±4.0a ±4.4a

22 Caseinolysis (proteose peptone formation) in CNH and LPS treated glands

23 Uric acid in CNH / LPS treated glands

24 Nitrate in CNH and LPS treated glands

25 Major conclusions Our data suggest that XO is post-transcriptional regulated through allocation of substrate (xanthine) availability. Together with lactic peroxidase they involve in the oxidative (mostly nitrosative) stress in certain type of sub-clinical mastitis. This system is the main driving force of oxidative/nitosative stress in E.Coli/LPS driven mastitis.

26 The Jekyll and Hyde sides of uric acid
Uric acid is a major anti-oxidant in blood plasma and milk However, uric acid is also a danger signal that alerts the immune system to dying cells (Nature 425: 516, 2003). In hyperuricemia, crystals of uric acid can precipitate in joins, where they cause gout and/or in other tissues causing inflammation. Does XO-depended gouty inflammation involve in the pathogenesis induced by E. coli/LPS in the mammary gland ?

27 Thank you: I hope that this lecture will contribute to our ability to
raise healthier cows and produce better dairy products BOLFA 2006


Download ppt "Nissim Silanikove, Fira Shapiro, Adi Rauch & Gabriel Leitner"

Similar presentations


Ads by Google